Figure (Lilly)
Onswik Injection, Solution
Product Images NDC 0002-5137
42 FDA label images from Eli Lilly And Company · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 42 technical images submitted to the FDA as part of the official labeling for Onswik (NDC 0002-5137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Onswik Kp Ifu F1 U1000 V1)
ONSWIK KwikPen disposable injection pen for subcutaneous use, shown with a green cap removed and placed beside the dial. The pen has a white body with a green cap and a dose window displaying dose settings. It is used for injection, solution of insulin efsitora alfa-gobe, manufactured by Eli Lilly and Company.*
Figure (Onswik Kp Ifu F1 U500 V1)
ONSWIK KwikPen insulin efsitora alfa-gobe injection, solution in a subcutaneous injection pen device. The pen shown is primarily white and gray with a yellow dose knob at the distal end. A dose window is visible on the side of the pen showing a partial dose measurement scale. No strength or labeler text is visible on the pen in the image.*
Figure (Onswik Kp Ifu F10 U1000 V1)
Illustration showing a close-up view of an ONSWIK KwikPen dose selector with a red arrow pointing right toward the dose increment display, indicating how to adjust the insulin dose on the injection pen device.*
Figure (Onswik Kp Ifu F10 U500 V1)
An instructional diagram showing the dosing window of the ONSWIK KwikPen insulin injector. The display indicates dose increments marked 0, 5, and 10 units, with a red arrow pointing to the dose selector mechanism.*
Figure (Onswik Kp Ifu F11 V1)
An instructional line drawing showing a person holding an ONSWIK KwikPen insulin injection device. The right hand is positioned near the pen tip, seemingly preparing to use the injection pen. The image likely demonstrates how to handle or prepare the KwikPen for subcutaneous injection.*
Figure (Onswik Kp Ifu F12 U1000 V1)
Instructional illustration depicting a hand holding an ONSWIK KwikPen insulin injection device. The image shows the tip of the pen with a protective cap being removed by pulling it downward. A circular inset highlights the needle detail at the top of the pen.*
Figure (Onswik Kp Ifu F12 U500 V1)
An instructional illustration showing a person holding an ONSWIK KwikPen insulin injection device. The image highlights the needle and the proper orientation of the injection pen, focusing on inserting or removing the pen cap with an arrow indicating upward movement.*
Figure (Onswik Kp Ifu F13 U1000 V1)
An illustration showing the dose selector window of the ONSWIK KwikPen insulin injection device. The window displays dose increments in units, with markings including 0, 10, and 20, and a red indicator aligned just before the 10-unit mark. The pen's dose selector knob is highlighted in green.*
Figure (Onswik Kp Ifu F13 U500 V1)
An illustration showing a close-up view of the dose selector window on an ONSWIK KwikPen injection device. The display shows a numeric dose setting with a red indicator pointer between the numbers 0 and 5, likely representing insulin units to be administered. The pen body is partially visible with yellow components on the right side.*
Figure (Onswik Kp Ifu F14 U1000 V1)
Instructional illustration showing a close-up of a hand holding an ONSWIK KwikPen insulin injection device, with a red arrow indicating the direction to pull or slide a green component, likely part of the device's preparation or dose-setting mechanism.*
Figure (Onswik Kp Ifu F14 U500 V1)
An instructional illustration showing a hand holding an ONSWIK KwikPen insulin injection device. The image focuses on the pen's dosage window, displaying units between 40 and 50, with a red arrow pointing upward beside the dosage window, indicating dosage adjustment or increment.*
Figure (Onswik Kp Ifu F15 U1000 V1)
An illustration showing a close-up view of a dosing window on an ONSWIK KwikPen insulin injection device. The image highlights the dose scale marked in units, with a red arrow pointing at a dose level near 80 units, demonstrating dose selection on the pen.*
Figure (Onswik Kp Ifu F15 U500 V1)
An instructional illustration showing a close-up view of a dosage dial on a pen-style injector device. The dial display numbers range from 70 to 90, with a red indicator pointing at approximately 80 units. The pen has a yellow button or end cap on the right side. This image likely relates to setting or reading the dose on an ONSWIK KwikPen injection device.*
Figure (Onswik Kp Ifu F16 U1000 V1)
An illustration showing part of an insulin pen dose window calibrated in units. The image highlights a dose setting near 140 units, with a red arrow pointing to the number 140 on the dial scale. The background includes calibration marks in increments of 10 units and a green component on the right side.*
Figure (Onswik Kp Ifu F16 U500 V1)
An illustrated close-up of a dosing window and scale on a pen injector, showing dose markings from 5 to 40 units and a red indicator aligned near the 130 mark on a numbered scale. The image includes a red arrow pointing at the red dose indicator on the pen. This likely relates to the dose selection or administration feature of the ONSWIK KwikPen, insulin efsitora alfa-gobe injection.*
Figure (Onswik Kp Ifu F17 U1000 V1)
Illustration showing recommended subcutaneous injection sites for ONSWIK KwikPen (insulin efsitora alfa-gobe). The highlighted areas include the abdomen, outer thighs, upper buttocks, and upper outer arms on a human body diagram from front and back views.*
Figure (Onswik Kp Ifu F17 U500 V1)
Illustration showing recommended subcutaneous injection sites for ONSWIK KwikPen insulin efsitora alfa-gobe. Highlighted areas include the abdomen (front), upper outer arms, front thighs, and upper buttocks (back) on a human figure.*
Figure (Onswik Kp Ifu F18 V1)
An illustration of a stopwatch showing a five-second interval. The stopwatch face is marked with the number '5' and a shaded area indicating the passage of five seconds, likely indicating a recommended time duration for an action related to the product.*
Figure (Onswik Kp Ifu F19 U1000 V1)
Illustration showing a person injecting a subcutaneous injection into the abdomen. The image depicts one hand pulling the skin taut while the other hand inserts a syringe needle at an angle into the abdominal area, indicating proper technique for subcutaneous injection.*
Figure (Onswik Kp Ifu F19 U500 V1)
An instructional illustration showing a person self-administering a subcutaneous injection in the abdominal area using a KwikPen. The image highlights proper hand placement and injection technique for the ONSWIK KwikPen insulin efsitora alfa-gobe injection.*
Figure (Onswik Kp Ifu F2 V1)
A yellow warning label with black text stating: 'DO NOT TRANSFER TO A SYRINGE SEVERE OVERDOSE CAN RESULT.' The label includes a black exclamation mark inside a triangle on the left side, indicating caution.*
Figure (Onswik Kp Ifu F20 V1)
Instructional diagram showing a hand holding an ONSWIK KwikPen insulin injection device with the cap being removed, indicated by a red arrow pointing away from the pen. The image depicts the preparation step for subcutaneous administration of insulin efsitora alfa-gobe.*
Figure (Onswik Kp Ifu F21 V1)
Illustration showing a hand holding an ONSWIK KwikPen injection pen, used for subcutaneous administration of insulin efsitora alfa-gobe. The pen has a visible label with yellow background, and a red schematic arrow indicating the direction of use or operation of the device.*
Figure (Onswik Kp Ifu F22 U1000 V1)
An instructional illustration showing the ONSWIK KwikPen with a red arrow indicating removal of the pen cap. The pen is labeled for insulin efsitora alfa-gobe injection, with a visible caution label and a green dose knob on the end.*
Figure (Onswik Kp Ifu F22 U500 V1)
An instructional diagram showing the ONSWIK KwikPen insulin efsitora alfa-gobe injection pen with its cap being removed, indicated by a red arrow pointing away from the pen, illustrating how to prepare the device for use.*
Figure (Onswik Kp Ifu F3 U1000 V1)
Illustration diagram showing the parts of the ONSWIK KwikPen insulin efsitora alfa-gobe injection device. Labeled components include the Pen Cap with a Cap Clip, Cartridge Holder containing the insulin cartridge and Rubber Seal, Plunger, Pen Body with Label, Dose Window displaying units, Dose Indicator, and Dose Knob for dose selection.*
Figure (Onswik Kp Ifu F3 U500 V1)
Illustration diagram showing the parts of the ONSWIK KwikPen injection device. Labeled components include Pen Cap with Cap Clip, Rubber Seal, Cartridge Holder with a warning label, Plunger, Pen Body with Label, Dose Window with Dose Indicator, and Dose Knob. This diagram outlines the structural elements of the subcutaneous insulin injection pen.*
Figure (Onswik Kp Ifu F4 U1000 V1)
Illustration showing parts of a pen needle for injection, labeled as Outer Needle Shield, Inner Needle Shield, Needle, and Paper Tab. Also depicted is a green Dose Knob, likely part of a pen injector device. The needles are not included in this diagram.*
Figure (Onswik Kp Ifu F4 U500 V1)
Illustration showing pen needle parts including outer needle shield, inner needle shield, needle, and paper tab, with a labeled photo of a yellow dose knob for a pen injection device.*
Figure (Onswik Kp Ifu F5 U1000 V1)
Label segment showing the strength designation 1,000 units per mL for ONSWIK KwikPen (insulin efsitora alfa-gobe) injection solution, subcutaneous, distributed by Eli Lilly and Company.*
Figure (Onswik Kp Ifu F5 U500 V1)
Label detail showing the dosage strength of ONSWIK KwikPen as 500 units per milliliter indicated on a yellow background with black text. This specifies the concentration of insulin efsitora alfa-gobe in the injection solution.*
Figure (Onswik Kp Ifu F6 V1)
An instructional diagram showing the ONSWIK KwikPen with an arrow indicating the removal of the pen cap from the injection pen. The pen is shown with a yellow warning label near the tip.*
Figure (Onswik Kp Ifu F7 V1)
An instructional illustration showing a hand removing or twisting off the cap from a pen-style injection device, indicated by a curved red arrow. The focus is on preparing the device for use, likely relevant to a medication delivery pen such as ONSWIK KwikPen.*
Figure (Onswik Kp Ifu F8 V1)
An instructional illustration showing how to remove the cap from an ONSWIK KwikPen injection device by twisting. The image depicts a red arrow indicating the direction to twist the cap off the pen. This diagram likely relates to preparing the insulin efsitora alfa-gobe injection for subcutaneous use.*
Figure (Onswik Kp Ifu F9 V1)
An instructional illustration showing the removal of a needle cap from the ONSWIK KwikPen injection device. It depicts the needle cap on the left with an arrow pointing left labeled 'Keep', a needle in the center labeled 'Throw Away', and the pen needle attached to the pen on the right with a caution symbol.*
Figure (Onswik Qr)
Package Carton – Humalog Kwikpen U-1000 Carton (Onswik U1000 Kpen 144 00)
ONSWIK KwikPen injection, solution with insulin efsitora alfa-gobe 1,000 units per mL (U-1,000) in a 3 mL prefilled pen. For subcutaneous use, single patient use only, and use once weekly. Manufactured by Eli Lilly and Company. The label notes that needles are not included and provides storage instructions to keep the pen refrigerated.*
Package Carton – Onswik Kwikpen U-500 Carton (Onswik U500 Kpen 143 00)
ONSWIK KwikPen 500 units per mL (U-500) injection is a prefilled insulin efsitora alfa-gobe delivery device for subcutaneous use. The carton indicates a single 3 mL prefilled pen intended for single patient use only, with a weekly dosing schedule. The labeler is Eli Lilly and Company. Storage instructions advise refrigeration between injections.*
Figure 1 (Onswik Uspi F1 V1)
A line graph depicting glucose infusion rate (mg/kg/min) over time post injection (days) ranging from 0 to 7. The graph shows a fluctuating pattern with a generally stable glucose infusion rate around 2 mg/kg/min throughout the 7-day period.*
Figure 2 (Onswik Uspi F2 V1)
A line graph displaying fasting blood glucose levels (mg/dL) over 26 weeks from randomization for four patient groups: ONSWIK with OTSD, ONSWIK without OTSD, Degludec with baseline FBG ≤120, and Degludec with baseline FBG >120. The chart includes the number of patients at various time points below the graph.*
Figure 3 (Onswik Uspi F3 V1)
A line graph depicting fasting blood glucose levels (mg/dL) over 26 weeks from randomization. It compares four groups: ONSWIK KwikPen with OTSD, ONSWIK KwikPen without OTSD, and two glargine groups split by baseline fasting blood glucose levels (<=120 and >120 mg/dL). Patient counts for each group at various weeks are listed below the graph.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
